Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.
SALICYCLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF
申请人:The Governing Council of the University of Toronto
公开号:US20150158894A1
公开(公告)日:2015-06-11
The present invention relates to novel compounds, compositions containing same and methods for inhibiting STAT3 and/or STAT5 activity or for the treatment of a STAT3 or STAT5-dependent cancer using said compounds; or a pharmaceutically acceptable salt, solvate or prodrug thereof.
Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
申请人:The Governing Council of the University of Toronto
公开号:US10377780B2
公开(公告)日:2019-08-13
The present invention relates to novel compounds, compositions containing same and methods for inhibiting STAT3 and/or STAT5 activity or for the treatment of a STAT3 or STAT5-dependent cancer using said compounds;
or a pharmaceutically acceptable salt, solvate or prodrug thereof.